| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034840535 |
| P356 | DOI | 10.1038/SJ.LEU.2402798 |
| P698 | PubMed publication ID | 12592327 |
| P5875 | ResearchGate publication ID | 10895987 |
| P2093 | author name string | Lee KH | |
| Lee JS | |||
| Lee JH | |||
| Park CJ | |||
| Kim WK | |||
| Chi HS | |||
| Seo EJ | |||
| Shin YR | |||
| P2860 | cites work | Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients | Q28216361 |
| Proposals for the classification of the myelodysplastic syndromes | Q28275931 | ||
| Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes | Q29037826 | ||
| Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival | Q44154368 | ||
| World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. | Q46038765 | ||
| Application of the International Prognostic Scoring System for myelodysplastic syndromes. | Q53343336 | ||
| Comparisons of prognostic scoring systems for myelodysplastic syndromes: a Korean multicenter study. | Q53345234 | ||
| Prediction of 18-month survival in patients with primary myelodysplastic syndrome. A regression model and scoring system based on the combination of chromosome findings and the Bournemouth score. | Q64894605 | ||
| Prognostic factors of myelodysplastic syndromes--a simplified 3-D scoring system | Q68741156 | ||
| Myelodysplastic syndromes: a scoring system with prognostic significance | Q70057242 | ||
| Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Anemia Study Group of the Ministry of Health and Welfare | Q72118428 | ||
| Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome. A study on 68 Chinese patients in Taiwan | Q72458741 | ||
| Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients | Q73186917 | ||
| Myelodysplastic syndromes in Thailand: a retrospective pathologic and clinical analysis of 117 cases | Q74752110 | ||
| Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution | Q77136351 | ||
| P433 | issue | 2 | |
| P921 | main subject | World Health Organization | Q7817 |
| P304 | page(s) | 305-313 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Leukemia | Q6534498 |
| P1476 | title | Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome | |
| P478 | volume | 17 |
| Q37564763 | A mechanism for 1,4-Benzoquinone-induced genotoxicity. |
| Q53241698 | A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification. |
| Q33693781 | A primary care approach to myelodysplastic syndromes |
| Q35265834 | A prospective multicenter observational study of decitabine treatment in Korean patients with myelodysplastic syndrome |
| Q36431041 | Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how? |
| Q51815934 | Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidity. |
| Q33368341 | Chronic myelomonocytic leukemia: lost in classification? |
| Q33429792 | Clinical Prognostic Factors in 86 Chinese Patients with Primary Myelodysplastic Syndromes and Trisomy 8: A Single Institution Experience |
| Q44233301 | Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries |
| Q33651786 | Clinicohematological and cytogenetic profile of myelodysplastic syndromes in Pakistan-compare and contrast |
| Q53509758 | Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies. |
| Q40352317 | Decreased incidence of febrile episodes with antibiotic prophylaxis in the treatment of decitabine for myelodysplastic syndrome |
| Q34612063 | Distinct clinical and experimental characteristics in the patients younger than 60 years old with myelodysplastic syndromes |
| Q37665288 | Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS). |
| Q33411124 | Dysplasia features of myelodysplastic syndrome in ethnically Chinese people |
| Q33417395 | Epidemiologic study of myelodysplastic syndromes in a multiethnic, inner city cohort |
| Q92383194 | Evaluation of different scoring systems and gene mutations for the prognosis of myelodysplastic syndrome (MDS) in Chinese population |
| Q35263145 | High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes |
| Q35567932 | Immune dysregulation in myelodysplastic syndrome |
| Q52721521 | Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome. |
| Q36838132 | Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea |
| Q27023457 | Murine xenogeneic models of myelodysplastic syndrome: an essential role for stroma cells |
| Q54738765 | Myelodysplastic Syndrome in Pakistan: Clinicohematological Characteristics, Cytogenetic Profile, and Risk Stratification. |
| Q51396075 | Myelodysplastic syndrome in New Zealand and Australia. |
| Q44125500 | Myelodysplastic syndrome with chromosome 5 abnormalities: a nationwide survey in Japan |
| Q64063404 | Pilot Study of an Integrative New Tool for Studying Clinical Outcome Discrimination in Acute Leukemia |
| Q53223243 | Prognosis in myelodysplastic syndromes: are the new classifications useful? |
| Q79239990 | Recent publications in hematological oncology |
| Q46727255 | Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). |
| Q55041529 | Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals. |
| Q33388797 | Refractory cytopenia with unilineage dysplasia: analysis of prognostic factors and survival in 126 patients |
| Q38095121 | Review of therapeutic options and the management of patients with myelodysplastic syndromes |
| Q53542725 | The clinical, haematological and morphological profile of patients with myelodysplastic syndromes: a single institution experience from Turkey. |
| Q47217804 | Trisomy 8 is the most frequent cytogenetic abnormality in de novo myelodysplastic syndrome in China |
| Q24605618 | Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations |
| Q38039381 | What's all the fuss about? facts and figures about bone marrow failure and conditions |
| Q53561569 | World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. |
Search more.